Go Pro

Allogene Therapeutics (ALLO) Institutional Ownership

Allogene Therapeutics logo
$1.99 -0.01 (-0.50%)
As of 09/1/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)

Current
Institutional Ownership
Percentage
83.63%
Number of
Institutional Buyers
(last 12 months)
82
Total
Institutional Inflows
(last 12 months)
$187.14M
Number of
Institutional Sellers
(last 12 months)
32
Total
Institutional Outflows
(last 12 months)
$25.31M
Get ALLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALLO Institutional Buying and Selling by Quarter

Allogene Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/27/2026 Corient Private Wealth LP41,100$85K0.0%N/A0.012%
8/23/2026 Frazier Life Sciences Management L.P.22,446,668$46.69M1.0%+491.2%6.497%
8/21/2026 AXQ Capital LP83,217$173K0.0%+12.6%0.024%
8/20/2026 Headlands Technologies LLC205,453$427K0.0%-22.7%0.059%
8/20/2026 GTS Securities LLC13,220$27K0.0%N/A0.004%
8/18/2026 Coastal Bridge Advisors LLC21,789$45K0.0%N/A0.006%
8/18/2026 Public Employees Retirement System of Ohio266,417$554K0.0%N/A0.077%
8/17/2026 Corient Private Wealth LP40,793$85K0.0%N/A0.012%
8/17/2026 Bank of America Corp DE3,187,320$6.63M0.0%N/A0.923%
8/15/2026 Man Group plc701,901$1.46M0.0%N/A0.203%
8/14/2026 Hsbc Holdings PLC259,747$557K0.0%N/A0.075%
8/14/2026 Primecap Management Co. CA13,123,440$27.30M0.0%N/A3.802%
8/14/2026 Canada Pension Plan Investment Board115,500$240K0.0%N/A0.033%
8/14/2026 Legal & General Group Plc25,743$54K0.0%N/A0.007%
8/14/2026 The Manufacturers Life Insurance Company 426,274$887K0.0%N/A0.124%
8/14/2026 Partners Capital Investment Group LLP161,597$336K0.0%N/A0.047%
8/14/2026 Algert Global LLC122,420$255K0.0%-73.6%0.035%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.322,827$671K0.0%N/A0.094%
8/13/2026 Bank of Nova Scotia97,400$203K0.0%N/A0.028%
8/12/2026 Quantbot Technologies LP116,933$243K0.0%N/A0.034%
8/12/2026 Ieq Capital LLC580,371$1.21M0.0%N/A0.168%
8/11/2026 E Fund Management Co. Ltd.47,593$99K0.0%N/A0.014%
8/7/2026 BlackRock Inc.30,146,963$62.71M0.0%N/A8.734%
8/7/2026 Pallas Capital Advisors LLC11,844$25K0.0%N/A0.003%
8/7/2026 Deutsche Bank AG281,949$586K0.0%N/A0.082%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.547,189$1.14M0.0%N/A0.159%
8/6/2026 Bank of New York Mellon Corp727,182$1.51M0.0%N/A0.211%
8/6/2026 State of Wyoming33,840$70K0.0%N/A0.010%
8/6/2026 GSA Capital Partners LLP285,590$594K0.0%N/A0.083%
8/3/2026 Walleye Capital LLC3,268,012$6.80M0.0%N/A0.947%
7/9/2026 Hennion & Walsh Asset Management Inc.722,928$1.50M0.0%N/A0.209%
7/8/2026 Westmount Partners LLC36,000$75K0.0%N/A0.010%
5/21/2026 Essential Partners LLC19,410$47K0.0%+525.9%0.008%
5/19/2026 Bank of America Corp DE2,134,473$5.21M0.0%+111.9%0.872%
5/19/2026 Bull Harbor Capital LLC12,703$31K0.0%N/A0.005%
5/18/2026 Royal Bank of Canada56,532$138K0.0%+15.9%0.023%
5/16/2026 The Manufacturers Life Insurance Company654,180$1.60M0.0%+35.0%0.267%
5/14/2026 Renaissance Technologies LLC2,139,328$5.22M0.0%-2.2%0.874%
5/14/2026 Public Employees Retirement System of Ohio177,875$434K0.0%N/A0.073%
5/7/2026 Dimensional Fund Advisors LP1,201,655$2.93M0.0%+25.5%0.491%
Rickards Predicts: Trump to buy tiny $2 stock? (Ad)

Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the largest mineral reserve in the country - enough gold for a new Fort Knox, enough copper to rebuild the U.S. electric grid 25 times over. The Trump administration has previously staked positions in MP Materials, Lithium America, Trilogy Metals, and USA Rare Earth - each time shares moved higher. A landmark policy decision expected before November 3 could reprice this stock from $2 to $20 or more within a year.tc pixel

Click here to see why Rickards believes this stock is next
5/5/2026 Bank of New York Mellon Corp395,187$964K0.0%-2.6%0.161%
5/1/2026 Candriam S.C.A.2,997,318$7.31M0.0%+30.0%1.224%
4/30/2026 Hsbc Holdings PLC260,404$638K0.0%+75.8%0.106%
4/30/2026 Harold Davidson & Associates Inc.289,222$706K0.3%+48.5%0.118%
4/29/2026 R Squared Ltd45,245$110K0.1%-47.5%0.018%
4/28/2026 Abel Hall LLC26,647$65K0.0%+56.4%0.011%
4/20/2026 Kestra Private Wealth Services LLC10,909$27K0.0%N/A0.004%
4/17/2026 Krilogy Financial LLC16,780$40K0.0%N/A0.007%
4/16/2026 SG Americas Securities LLC15,390$38K0.0%-35.8%0.006%
3/20/2026 Hsbc Holdings PLC148,136$199K0.0%+57.5%0.061%
3/3/2026 Caitong International Asset Management Co. Ltd44,334$61K0.0%+84.4%0.020%
2/23/2026 Virtu Financial LLC42,351$58K0.0%+55.9%0.019%
2/19/2026 Invesco Ltd.609,807$835K0.0%+16.1%0.271%
2/18/2026 Mercer Global Advisors Inc. ADV29,512$40K0.0%+23.0%0.013%
2/18/2026 XTX Topco Ltd476,307$653K0.0%-38.5%0.212%
2/18/2026 Zacks Investment Management192,731$264K0.0%-63.4%0.086%
2/18/2026 Virtus Investment Advisers LLC176,178$241K0.1%+116.8%0.078%
2/18/2026 Quadrature Capital Ltd274,416$376K0.0%+15.3%0.122%
2/18/2026 Millennium Management LLC1,841,307$2.52M0.0%-45.7%0.819%
2/18/2026 Man Group plc526,106$721K0.0%+86.5%0.234%
2/17/2026 AQR Capital Management LLC1,429,247$1.96M0.0%-22.9%0.636%
2/17/2026 Price T Rowe Associates Inc. MD3,209,275$4.40M0.0%-12.7%1.428%
2/17/2026 Russell Investments Group Ltd.40,041$55K0.0%+83.3%0.018%
2/17/2026 Captrust Financial Advisors53,101$73K0.0%+237.9%0.024%
2/17/2026 Royal Bank of Canada48,794$67K0.0%-95.6%0.022%
2/17/2026 Graham Capital Management L.P.148,671$204K0.0%-24.7%0.066%
2/16/2026 Squarepoint Ops LLC104,656$143K0.0%-61.0%0.047%
2/16/2026 Barclays PLC642,687$880K0.0%+7.3%0.286%
2/13/2026 Marshall Wace LLP285,561$391K0.0%N/A0.127%
2/13/2026 CANADA LIFE ASSURANCE Co50,951$69K0.0%+28.2%0.023%
2/13/2026 Kalehua Capital Management LLC2,546,129$3.49M3.2%N/A1.133%
2/13/2026 Smartleaf Asset Management LLC28,927$38K0.0%N/A0.013%
2/13/2026 Headlands Technologies LLC46,778$64K0.0%-66.6%0.021%
2/13/2026 OpenArc Corporate Advisory LLC162,984$223K0.0%N/A0.073%
2/13/2026 Charles Schwab Investment Management Inc.1,355,809$1.86M0.0%+16.4%0.603%
2/13/2026 State Street Corp2,761,400$3.78M0.0%+0.2%1.229%
2/13/2026 Ieq Capital LLC435,267$596K0.0%+15.7%0.194%
2/13/2026 Wells Fargo & Company MN200,276$274K0.0%+38.3%0.089%
2/12/2026 HRT Financial LP72,751$99K0.0%-45.1%0.032%
2/12/2026 MetLife Investment Management LLC34,823$48K0.0%-39.2%0.015%
2/12/2026 Renaissance Technologies LLC2,187,084$3.00M0.0%-24.4%0.973%
2/12/2026 Dimensional Fund Advisors LP957,816$1.31M0.0%-54.2%0.426%
2/12/2026 Patient Square Capital LP4,963,756$6.80M1.5%+66.5%2.209%
2/11/2026 Primecap Management Co. CA8,139,840$11.15M0.0%+15.0%3.622%
2/11/2026 Deutsche Bank AG131,086$180K0.0%-6.9%0.058%
2/11/2026 Cerity Partners LLC97,909$134K0.0%-79.0%0.044%
2/11/2026 LPL Financial LLC170,750$234K0.0%-3.8%0.076%
2/11/2026 Harold Davidson & Associates Inc.194,753$267K0.1%-34.1%0.087%
2/10/2026 Goldman Sachs Group Inc.2,289,458$3.14M0.0%+90.2%1.019%
2/10/2026 Intech Investment Management LLC86,637$119K0.0%+20.5%0.039%
A weekly dividend fund holding Nvidia and Palantir (Ad)

CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.tc pixel

Watch the free presentation before this Thursday's payout
2/9/2026 Geode Capital Management LLC3,932,910$5.39M0.0%+2.6%1.750%
2/6/2026 GSA Capital Partners LLP613,998$841K0.1%+235.7%0.273%
2/5/2026 Navalign LLC49,398$68K0.0%-17.5%0.022%
1/30/2026 R Squared Ltd86,215$118K0.1%+40.5%0.038%
1/23/2026 Choreo LLC38,849$51K0.0%N/A0.017%
1/16/2026 Aberdeen Group plc2,086,332$2.86M0.0%+31.9%0.928%
1/1/2026 JPMorgan Chase & Co.908,725$1.13M0.0%-2.7%0.404%
11/19/2025 Caitong International Asset Management Co. Ltd24,047$30K0.0%+5,267.6%0.011%
11/17/2025 CANADA LIFE ASSURANCE Co39,730$50K0.0%+27.3%0.018%
11/17/2025 XTX Topco Ltd774,203$960K0.0%+2,687.7%0.345%


ALLO Institutional Ownership - Frequently Asked Questions

During the previous two years, 149 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), BlackRock Inc. ($62.71M), Frazier Life Sciences Management L.P. ($46.69M), Primecap Management Co. CA ($27.30M), Vanguard Group Inc. ($11.19M), Candriam S.C.A. ($7.31M), and Patient Square Capital LP ($6.80M).Learn more on Allogene Therapeutics' institutional investors.

83.63% of Allogene Therapeutics' stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings.

Of the 132 institutional investors that purchased Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($30.15M), Frazier Life Sciences Management L.P. ($19.65M), Primecap Management Co. CA ($16.33M), Bank of America Corp DE ($4.93M), Goldman Sachs Group Inc. ($4.83M), Lynx1 Capital Management LP ($4.67M), and Patient Square Capital LP ($4.09M).

Institutional investors have bought a total of 97,030,535 shares in the last 24 months. This purchase volume represents approximately $187.14M in transactions.

Of the 32 institutional investors that sold Allogene Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lynx1 Capital Management LP ($10.51M), Dimensional Fund Advisors LP ($1.78M), Millennium Management LLC ($1.55M), Royal Bank of Canada ($1.05M), Renaissance Technologies LLC ($754.48K), Price T Rowe Associates Inc. MD ($468.20K), and AQR Capital Management LLC ($424.31K).

Institutional investors have sold a total of 19,319,510 shares in the last 24 months. This volume of shares sold represents approximately $25.31M in transactions.



Institutional ownership data for NASDAQ:ALLO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/27/2026. New 13F filings are added each quarter as they're published.
From Our Partners